Postischemic vascular permeability requires both TLR-2 and TLR-4, but only TLR-2 mediates the transendothelial migration of leukocytes

Shock

Volumn 31, Issue 6, 2009, Pages 592-598

  Khandoga, Alexander Georg ^a   Khandoga, Andrej ^a   Anders, Hans Joachim ^b   Krombach, Fritz ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cell migration; Ischemia reperfusion; Leukocyte polarization; Vascular leakage

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL WALL; CONTROLLED STUDY; CREMASTER MUSCLE; IN VIVO STUDY; INNATE IMMUNITY; ISCHEMIA; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MOUSE; MUTANT; NONHUMAN; POLARIZATION; TISSUE INJURY; WILD TYPE;

ANIMALS; CAPILLARY PERMEABILITY; CELL ADHESION; CELL MOVEMENT; LEUKOCYTE COUNT; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROSCOPY, FLUORESCENCE; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 68049110594     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318193c859     Document Type: Article

References (41)

1. Seal JB, Gewertz BL: Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg 19:572-584, 2005.
2. Khandoga A, Kessler JS, Hanschen M, Khandoga AG, Burggraf D, Reichel C, Hamann GF, Enders G, Krombach F: Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver. J Leukoc Biol 79:1295-1305, 2006.
3. Nedrebo T, Reed RK, Berg A: Effect of alpha-trinositol on interstitial fluid pressure, edema generation, and albumin extravasation after ischemia-reperfusion injury in rat hind limb. Shock 20:149-153, 2003.
4. Medzhitov R: TLR-mediated innate immune recognition. Semin Immunol 19:1-2, 2007.
5. Tsujimoto H, Ono S, Efron PA, Scumpia PO, Moldawer LL, Mochizuki H: Role of Toll-like receptors in the development of sepsis. Shock 29:315-321, 2008.
6. Lu CY, Hartono J, Senitko M, Chen J: The inflammatory response to ischemic acute kidney injury: a result of the 'right stuff' in the 'wrong place'? Curr Opin Nephrol Hypertens 16:83-89, 2007.
7. Kaczorowski DJ, Nakao A, Mollen KP, Vallabhaneni R, Sugimoto R, Kohmoto J, Tobita K, Zuckerbraun BS, McCurry KR, Murase N, et al.: Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 84:1279-1287, 2007.
8. Hua F, Ha T, Ma J, Li Y, Kelley J, Gao X, Browder IW, Kao RL, Williams DL, Li C: Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J Immunol 178:7317-7324, 2007.
9. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, Tobias PS, Mackman N, McKay DB: TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and - independent pathways. J Immunol 178:6252-6258, 2007.
10. Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF, Thuillez C, Richard V: Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 27:1064-1071, 2007.
11. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR: Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26:430-437, 2006.
12. Shimamoto A, Pohlman TH, Shomura S, Tarukawa T, Takao M, Shimpo H: Toll-like receptor 4 mediates lung ischemia-reperfusion injury. Ann Thorac Surg 82:2017-2023, 2006.
13. Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995, 2004.
14. Sabroe I, Dower SK, Whyte MK: The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin Infect Dis 41(suppl 7):S421-S426, S421-S426, 2005.
15. Baumgarten G, Knuefermann P, Schuhmacher G, Vervolgyi V, von Rappard J, Dreiner U, Fink K, Djoufack C, Hoeft A, Grohe C, et al.: Toll-like receptor 4, nitric oxide, and myocardial depression in endotoxemia. Shock 25:43-49, 2006.
16. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749-3752, 1999.
17. Baez S: An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 5:384-394, 1973.
18. Heit B, Liu L, Colarusso P, Puri KD, Kubes P: PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP. J Cell Sci 121:205-214, 2008.
19. Furst R, Bubik MF, Bihari P, Mayer BA, Khandoga AG, Hoffmann F, Rehberg M, Krombach F, Zahler S, Vollmar AM: Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivo. Mol Pharmacol 74(1):1-8, 2008.
20. Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR, Billiar TR: HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 204:2913-2923, 2007.
21. Zhang JX, Wu HS, Wang H, Zhang JH, Wang Y, Zheng QC: Protection against hepatic ischemia/reperfusion injury via downregulation of Toll-like receptor 2 expression by inhibition of Kupffer cell function. World J Gastroenterol 11:4423-4426, 2005.
22. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117:2847-2859, 2007.
23. Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, Salomone S, Moskowitz MA: Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 28(5):927-938, 2008.
24. Hoth JJ, Hudson WP, Brownlee NA, Yoza BK, Hiltbold EM, Meredith JW, McCall CE: Toll-like receptor 2 participates in the response to lung injury in a murine model of pulmonary contusion. Shock 28:447-452, 2007.
25. Bruns B, Maass D, Barber R, Horton J, Carlson D: Alterations in the cardiac inflammatory response to burn trauma in mice lacking a functional Toll-like receptor 4 gene. Shock 30:740-746, 2008.
26. Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, Newburger PE, Finberg RW: Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100:1860-1868, 2002.
27. Harokopakis E, Albzreh MH, Martin MH, Hajishengallis G: TLR2 transmodulates monocyte adhesion and transmigration via Rac1- and PI3K-mediated inside-out signaling in response to Porphyromonas gingivalis fimbriae. J Immunol 176:7645-7656, 2006.
28. Watts C, Zaru R, Prescott AR, Wallin RP, West MA: Proximal effects of Toll-like receptor activation in dendritic cells. Curr Opin Immunol 19:73-78, 2007.
29. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG: Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 1:533-540, 2000.
30. Lasunskaia EB, Campos MN, de Andrade MR, Damatta RA, Kipnis TL, Einicker-Lamas M, Da Silva WD: Mycobacteria directly induce cytoskeletal rearrangements for macrophage spreading and polarization through TLR2-dependent PI3K signaling. J Leukoc Biol 80:1480-1490, 2006.
31. van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, Nawroth PP, Bierhaus A, Tracey KJ, van der Poll T: Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 31:280-284, 2009.
32. Phillipson M, Kaur J, Colarusso P, Ballantyne CM, Kubes P: Endothelial domes encapsulate adherent neutrophils and minimize increases in vascular permeability in paracellular and transcellular emigration. PLoS ONE 3(2):e1649, 2008.
33. Dull RO, Garcia JG: Leukocyte-induced microvascular permeability: how contractile tweaks lead to leaks. Circ Res 90:1143-1144, 2002.
34. Hollenberg SM, Guglielmi M, Parrillo JE: Discordance between microvascular permeability and leukocyte dynamics in septic inducible nitric oxide synthase deficient mice. Crit Care 11:R125, 2007.
35. Breslin JW, Wu MH, Guo M, Reynoso R, Yuan SY: Toll-like receptor 4 contributes to microvascular inflammation and barrier dysfunction in thermal injury. Shock 29:349-355, 2008.
36. McKenzie JA, Ridley AJ: Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability. J Cell Physiol 213:221-228, 2007.
37. Zittermann SI, Issekutz AC: Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation. J Leukoc Biol 80:247-257, 2006.
38. Godzich M, Hodnett M, Frank JA, Su G, Pespeni M, Angel A, Howard MB, Matthay MA, Pittet JF: Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia-reperfusion injury in rats. FASEB J 20:1519-1521, 2006.
39. Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, Sessa WC, Ignarro LJ, Cirino G: Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci U S A 102:904-908, 2005.
40. Lee JY, Lowell CA, Lemay DG, Youn HS, Rhee SH, Sohn KH, Jang B, Ye J, Chung JH, Hwang DH: The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4. Biochem Pharmacol 70:1231-1240, 2005.
41. He H, Genovese KJ, Nisbet DJ, Kogut MH: Profile of Toll-like receptor expressions and induction of nitric oxide synthesis by Toll-like receptor agonists in chicken monocytes. Mol Immunol 43:783-789, 2006.